Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)
Clinical trial NCT00941603 · COMPLETED
Trial details
- NCT number
- NCT00941603
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-29
- Primary completion
- 2010-02-22
- Enrollment
- 619
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.